Posted on 14/09/2017
For immediate release. 14 September, 2017. Rayner are proud to announce the launch of the newest member of the RayOne family of preloaded IOLs: the RayOne Trifocal, to be unveiled at the upcoming 2017 ESCRS conference in Lisbon. Product availability will be from 9 October 2017 to all CE registered markets. The most advanced lens design Rayner
Posted on 7/09/2017
For immediate release. Rayner strengthens commitment to US market with subsidiary Rayner Surgical Inc. 7 September, 2017. With a large part of 2016 and 2017 focused on European expansion, Rayner announced today its investment into the US market with the establishment of a dedicated subsidiary, ‘Rayner Surgical Inc.’Based out of New York, Rayner Surgical Inc. will provide
Posted on 11/07/2017
For immediate release. Date: 11 July, 2017. RayOne Fully Preloaded IOL Injection System. Now available in Brazil. More surgeons to access the smallest Fully Preloaded IOL Incision Rayner announced today the latest update in the RayOne story: registration of the RayOne Aspheric and Spheric monofocal fully preloaded IOL injection systems has been listed in the Federal Register
Posted on 19/06/2017
An experimental study was recently conducted to compare current fully preloaded intraocular lens (IOL) injection systems on the market.
The study explored wound architecture after IOL implantation and the overall ease and speed...
Posted on 24/04/2017
For immediate release. Rayner marks ten years of C-flex in the USA 14 March 2017. Worthing, United Kingdom. Rayner announced today that it will mark an important milestone next month: the ten year anniversary of US Food and Drug Administration (FDA) approval of C-flex 570C monofocal Intraocular Lens (IOL) for commercial use in the United States of America.
Posted on 27/02/2017
For immediate release. March 02, 2017 – Worthing, United Kingdom. Rayner announced today that a selection of models in their Sulcoflex range of pseudophakic supplementary IOLs have received Chinese Food and Drug Administration (CFDA) approval and are to be launched in market in 2017. Rayner is the first manufacturer to make a supplementary IOL available to surgeons in
Posted on 15/02/2017
In 2016, 773 Rayner IOLs were used to restore the sight of some of Bangladesh’s poorest and most isolated people, according to the recent Annual IMPACT partner report. There were no complications found during post-operative follow up visi...
Posted on 31/01/2017
Phoenix Equity Partners ("Phoenix"), a leading UK middle-market private equity firm, today announces an investment in Rayner Surgical Group (“Rayner” or “the Company”) alongside the current management team...
Posted on 16/01/2017
For immediate release. Date: 16th January 2017 Rayner continues growth in 2017 with direct presence in Portugal. Following on from their European expansion in 2016 — direct entry into the Italian cataract market and direct entry into the Spanish cataract market — Rayner is pleased to announce its direct entry into the Portuguese cataract market. The entire Rayner IOL & injector portfolio,
Posted on 18/11/2016
Italian-speaking surgeons can now find a solution to their needs more efficiently and with greater ease thanks to the launch of an Italian translation of our global website. “Having recently announced our direct entry into Italy, it makes sense to offer surgeons an Italian translation of the Rayner website, joining our German, French and Spanish translations,” said